39.01
price down icon0.10%   -0.04
after-market アフターアワーズ: 39.17 0.16 +0.41%
loading
前日終値:
$39.05
開ける:
$39.28
24時間の取引高:
2.77M
Relative Volume:
0.93
時価総額:
$4.95B
収益:
$638.78M
当期純損益:
$-22.66M
株価収益率:
-223.68
EPS:
-0.1744
ネットキャッシュフロー:
$122.18M
1週間 パフォーマンス:
+9.18%
1か月 パフォーマンス:
+27.03%
6か月 パフォーマンス:
+134.72%
1年 パフォーマンス:
+199.85%
1日の値動き範囲:
Value
$38.19
$39.83
1週間の範囲:
Value
$34.57
$40.08
52週間の値動き範囲:
Value
$11.16
$40.08

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1098)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,178
Name
Twitter
@10xgenomics
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

Compare TXG vs VEEV, BTSG, TEM, HQY, HNGE

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TXG icon
TXG
10 X Genomics Inc
39.01 4.87B 638.78M -22.66M 122.18M -0.1744
VEEV icon
VEEV
Veeva Systems Inc
192.74 28.83B 3.32B 941.65M 1.64B 5.6161
BTSG icon
BTSG
Brightspring Health Services Inc
69.03 13.69B 13.65B 169.86M 412.12M 1.0758
TEM icon
TEM
Tempus Ai Inc
60.27 10.40B 1.36B -302.91M -219.93M -1.7182
HQY icon
HQY
Healthequity Inc
95.31 7.55B 1.34B 230.70M 440.96M 2.6695
HNGE icon
HNGE
Hinge Health Inc
84.05 6.42B 646.34M -512.40M 202.76M -6.6871

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-31 アップグレード William Blair Mkt Perform → Outperform
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Jul 01, 2026

Piper Sandler raises 10X Genomics stock price target on clinical pivot - Investing.com UK

Jul 01, 2026
pulisher
Jun 30, 2026

10x Genomics stock hits 52-week high at 37.58 USD - Investing.com

Jun 30, 2026
pulisher
Jun 30, 2026

Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider - GlobeNewswire Inc.

Jun 30, 2026
pulisher
Jun 28, 2026

10x Genomics, Inc.(NasdaqGS:TXG) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

10x Genomics Inc Class A Actuals & Estimates (FWB:1KJ) - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

1KJ Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

10x Genomics Inc Class A Actuals & Estimates (DUS:1KJ) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor - Yahoo Finance

Jun 26, 2026
pulisher
Jun 26, 2026

Price to earnings forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

10x Genomics Inc Class A Actuals & Estimates (MUN:1KJ) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to revenue forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

10x Genomics Inc Class A Actuals & Estimates (NASDAQ:TXG) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to EBIT forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Jun 26, 2026
pulisher
Jun 25, 2026

10x Genomics Inc Class A Actuals & Estimates (LSE:0A88) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Enterprise value to EBITDA forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

10x Genomics Inc Class A Actuals & Estimates (BIVA:TXG) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

TXG Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to earnings forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

10x genomics CEO Serge Saxonov sells $1.03m in stock By Investing.com - Investing.com Australia

Jun 24, 2026
pulisher
Jun 24, 2026

Form 4 10X Genomics Inc For: 24 June By Investing.com - Investing.com Australia

Jun 24, 2026
pulisher
Jun 24, 2026

10x genomics CEO Serge Saxonov sells $1.03m in stock - Investing.com

Jun 24, 2026
pulisher
Jun 24, 2026

10x Genomics Insider Sold Shares Worth $1,033,269, According to a Recent SEC Filing - marketscreener.com

Jun 24, 2026
pulisher
Jun 24, 2026

10x Genomics (TXG) CEO sells 30,000 shares under 10b5-1 plan - Stock Titan

Jun 24, 2026
pulisher
Jun 24, 2026

Why Is 10x Genomics (TXG) Stock Soaring Today - Yahoo Finance

Jun 24, 2026
pulisher
Jun 24, 2026

Price to book forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

10X Genomics Inc (TXG) Institutional Confidence - TradingKey

Jun 24, 2026
pulisher
Jun 22, 2026

10X Genomics stock hits 52-week high at 36.0 USD By Investing.com - Investing.com Australia

Jun 22, 2026
pulisher
Jun 22, 2026

10X Genomics stock hits 52-week high at 36.0 USD - Investing.com

Jun 22, 2026
pulisher
Jun 19, 2026

10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance

Jun 19, 2026
pulisher
Jun 19, 2026

10x Genomics boosts single cell proteomics with acquisition of Proteintech Genomics - SelectScience

Jun 19, 2026
pulisher
Jun 18, 2026

Insider Sell: Shehnaaz Suliman Sells Shares of 10x Genomics Inc (TXG) - GuruFocus

Jun 18, 2026
pulisher
Jun 18, 2026

10x Genomics (TXG) director Suliman sells 5,723 shares in Rule 10b5-1 trades - Stock Titan

Jun 18, 2026
pulisher
Jun 18, 2026

TXG - Finviz

Jun 18, 2026
pulisher
Jun 18, 2026

10x Genomics Expands Oncology Diagnostics Ambitions Through Cleveland Clinic Collaboration - BioPharma APAC

Jun 18, 2026
pulisher
Jun 18, 2026

10X Genomics stock rises on Cleveland Clinic partnership - Investing.com

Jun 18, 2026
pulisher
Jun 17, 2026

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer - BioSpace

Jun 17, 2026
pulisher
Jun 17, 2026

10x Genomics (TXG) Partners with Cleveland Clinic for Bladder Ca - GuruFocus

Jun 17, 2026
pulisher
Jun 17, 2026

10x Genomics and Cleveland Clinic Collaborate to Advance Researc - GuruFocus

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics (TXG) Stock Surges 4% Following Cleveland Clinic Bladder Cancer Research Agreement - Blockonomi

Jun 17, 2026
pulisher
Jun 17, 2026

10x Genomics, Inc and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer - marketscreener.com

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics stock rises on Cleveland Clinic partnership By Investing.com - Investing.com India

Jun 17, 2026
pulisher
Jun 17, 2026

10x Genomics partners with Cleveland Clinic on bladder cancer study By Investing.com - Investing.com Nigeria

Jun 17, 2026
pulisher
Jun 17, 2026

10x Genomics partners with Cleveland Clinic on bladder cancer study - Investing.com

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics Inc (TXG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics Inc (TXG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics Inc (TXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics Inc (TXG) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

10X Genomics Inc (TXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

10x Genomics, Cleveland Clinic study aims to predict bladder cancer treatment response - Stock Titan

Jun 17, 2026

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

10 X Genomics Inc (TXG) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
SULIMAN SHEHNAAZ
Director
Jun 16 '26
Sale
32.63
5,723
186,756
31,722
WAY WAY
$23.46
price up icon 9.47%
$50.07
price up icon 0.11%
$21.86
price up icon 1.25%
$27.36
price up icon 1.79%
$84.05
price down icon 1.20%
大文字化:     |  ボリューム (24 時間):